Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole
sodium 20 mg tablets to Eisai's Aciphex® 20 mg tablets following a single, oral 20 mg (1 x 20
mg) dose administration under fed conditions.